1.375% 16jan2030 (A19UUF)

There is nothing in the official BNOS Constitution or foundational bylaws that dictates a mandatory online post-presentation waiting period or abstract embargo for presenting companies.
GOOD JOB I/R.

I was hoping the webinar would have indicated they were digging the first treasure target. Really sad operationally. They are convinced the tech is accurate but can't get to the targets. I know the environment at Juno is difficult but at some point they have to perform.

"A dead tumor is a dead tumor" has to be one of the most scientifically illiterate statements in this entire discussion. By that logic every cancer therapy is identical because the goal is the same. That's basic science thrown out of the window.

You keep reducing oncology to a slogan

Ken griffen will find a way to act like it never happened, unfortunately.

But you should also know that at the end of the 12 month restriction you have to pay close to a thousand dollars to have the shares released to be tradeable. You will have to get an attorney's opinion to give to your broker, get Legacy to verify it and release them. They will charge you for this. Yo

Companies Using Ripple for Cross-Border Payments: The Full 2026 Picture
17 June 2026
https://memeburn.com/companies-using-ripple-for-cross-border-payments/

"...Ripple's cross-border payment network now includes over 300 financial institutions, with major 2026 additions l

DC-VAX was just derisked to/for BP. IMO. Combo platforms. Can’t ignore NWBO any longer. 🤷🏻‍♂️

For anybody who can't remember, $40 billion was taken from Fannie and Fred to bail out the solving banks. Then Hank Paulson did even more damage

Does anyone know if BA is invited to DC for the 250 years ceremony which could imply if he is one of the inner circle. Being with F2 for over 19 years, from my limited observation, he hasn’t yet brought any good luck to the stocks instead of pumping and dumping saga.
Fnma was $9.48 on July 3

Warren Buffett Breaks His Silence on the U.S. Stock Market

https://youtu.be/oIBwNHgJj08

This is the biggest thing since the Advent acquisition, if not bigger.

Never thought about that. That would certainly save them a few hundred million. Is there enough capacity, compression or whatever the criteria is to piggyback on Williams? Would they prefer to have their own control with a new station?

That would be just like Delfin to pivot after bat

..dude......will get 'em both, and the G-wagon is ordered, and the 4-runner......not firm on the wrangler, but definitely a wrangler............gotta fill up the garages with a new fleet.........boys toys................($40mios in the tip jar??)...............

.....the POS.....???.

Robert Half receives three Canadian HR Reporter Readers' Choice Awards 2026, for 11th consecutive yearJuly 3, 2026 12:38 PM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"July 3, 2026 /CNW/ - Global talent so

$OSRH to new long investors buy 10k shares and HOLD and while turning your 10k shares to 60k shares 👇 

•  Details: One non-transferable CVR per share held as of the record date (targeted for July 31, 2026). Subject to legal counsel approval.

•  Tiered Rewards: T

Slide16 “Overall Conclusions: The survival benefit associated with DCVax-L treatment reflects a true treatment affect and was underestimated in the original analysis”

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

i will wait for Monday to grab some more ??

Brazen22, you’re trying to reduce three years of regulatory progress to one sentence: “You don’t have an approved MAA.”

Of course we don’t — yet. Approval is the destination. We have a validated MAA. What matters is whether NWBO has completed the steps that regulators require before a

THATS WHEN i ACCUMULATE. At The hammerbottom.

Nonbelievers . . . . . C L E A R THE R U N W A Y
$3.50 CDN is pretty strong support.

https://investorshub.advfn.com/uimage/uploads/2026/7/3/vwgethg_july_3_2y_plunge_sell.jpg

Slides! JAMA study UNDERESTIMATED survival benefit

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

I agree with your thinking and also what needs to be considered is after decimating the board, just a desire to be acquired doesn’t automatically make that happen.  Some other party has to be interested in acquiring Amarin. What happens then if no one steps up?

This is another post built on false equivalence. Sharing Y-90 doesn't make two products the same any more than sharing aspirin makes every painkiller identical.

You keep calling them competitors while ignoring they're fundamentally different technologies. One is a hydrogel platform, t

Im glad I held my shares past $0.15